Stay updated on Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-09T20:54:49.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study's history, and the previous revision v3.6.6 was removed.
    Difference
    0.1%
    Check dated 2026-09-18T18:35:43.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A new entry for Revision: v3.6.6 was added to the Study Record History, replacing Revision: v3.6.5. This indicates a site release update applied to the ClinicalTrials.gov records.
    Difference
    0.1%
    Check dated 2026-08-28T17:34:17.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 was added to the study record history, indicating an update to the page, and the previous revision v3.6.4 was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-08-07T09:39:38.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The study's record history now includes a new Revision: v3.6.4 entry, replacing the previous Revision: v3.6.3 in the version list.
    Difference
    0.1%
    Check dated 2026-07-24T02:41:23.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry: v3.6.3, replacing the previous v3.6.1. This represents a minor metadata update to the study's record version on the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-07-02T13:56:48.000Z thumbnail image

Stay in the know with updates to Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.